Vertex Pharmaceuticals Inc. shares drop 1.74% to $190.97 Monday. This proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.26% to 4,479.71 and the Dow Jones Industrial Average DJIA rising 0.31% to 35,625.40.
Vertex Pharmaceuticals Inc. closed $92.48 short of its 52-week high ($283.45), which the company achieved on September 2nd. The stock underachieved as opposed to its competitors on Monday, as Johnson & Johnson JNJ rose 0.90% to $177.84, Merck & Co. Inc. MRK rose 1.58% to $77.93, and AbbVie Inc. ABBV rose 1.66% to $118.41.
Mayo Investment Advisers Llc initiated holdings in Vertex Pharmaceuticals Inc. The purchase prices were between $187.49 and $221.1, with an estimated average price of $209.31. The stock is now traded at around $190.970000. This purchase accounted for 3.01%. The holdings were 8,300 shares as of 2021-06-30. These are some of the major developments in the purchase and sell out pertaining to Vertex.